• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Factors Impacting Use of HER2 Therapies for NSCLC

Opinion
Video

Panelists discuss how payer perspectives and access challenges impact the utilization of HER2-directed therapies in NSCLC, examining barriers to treatment initiation and persistence, aligning provider and payer priorities in outcome assessment, the role of real-world evidence in decision-making and policy formation, and strategies for collaborative efforts between stakeholders to balance equitable access with cost management.

Related Videos
Dr Amrita Basu
Dr Eric Yang
Dr Adam Brufsky
4 Experts are featured in this series
4 Experts are featured in this series
4 experts are featured in this series.
4 experts are featured in this series.
An expert featured in this series.
© 2026 MJH Life Sciences
AJMC®
All rights reserved.